Receipt of PT, Chiropractic Care Reportedly Low for Comorbid Chronic LBP, Opioid Use Disorder
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 13, 2023 -- For Medicare beneficiaries with chronic low back pain (CLBP) and opioid use disorder (OUD), receipt of physical therapy (PT) and chiropractic care is low overall and lower for racial and ethnic minority groups, according to a study published online Sept. 12 in JAMA Network Open.
Fiona Bhondoekhan, from the Brown University School of Public Health in Providence, Rhode Island, and colleagues examined differences in receipt of PT or chiropractic care for CLBP among persons with comorbid OUD in a retrospective cohort study using a 20 percent random sample of national Medicare administrative data from Jan. 1, 2016, to Dec. 31, 2018. Data were analyzed for 69,362 Medicare beneficiaries.
The researchers found that 10.2 percent of all beneficiaries received any PT or chiropractic care three months after a new CLBP episode. Compared with non-Hispanic White patients, the odds of receiving chiropractic care within three months of CLBP diagnosis were lower for Black or African American and Hispanic persons after adjustment (adjusted odds ratios, 0.46 and 0.54, respectively). The longest median time to chiropractic care was seen for American Indian or Alaska Native and Black or African American persons (median, 8.5 and 7.0 days, respectively), while the shortest median time was seen for Asian or Pacific Islander persons (median, 0 days). For PT, no significant racial and ethnic differences were observed.
"Efforts are needed to elucidate and address the individual, practitioner, and system-level risk factors that limit racial equity in guideline-recommended pain management in general and for persons with OUD," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.